what is a tirzepatide vs. Semaglutide: You Should Know PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Learn how it works, side effects, dosing, and how to start treatment with Mobile Care Health.

Contents: GHK-Cu (Copper Peptide)

There is strong evidence to support the use of GLP-1 agonists in overweight or obese patients who have cardiovascular disease, impaired renal function or are at high risk of hypoglycaemia

(For a detailed history, I recommend Megan Molteni and Elaine Chens piece for STAT.) The benefits of these drugs are undeniable, but when it comes to evaluating their risks, we run into challenges that researchers are familiar with but that the public at large may not be aware of

Many endocrinologists are now recommending GLP-1 drugs as first line injectables therapy over the insulin for many Type II diabetes as GLP-1 benefits outweighs Insulin